- about us
- medical affairs
- investors & media
- Email Alerts
- Contact Us
SYMBODA, meaning “similar to the body,” is a solubilized female hormone technology for formulation of estradiol and progesterone identical in chemical structure to the estradiol and progesterone that women naturally produce.
SYMBODA technology is unique because it enables partial or complete solubilization of progesterone or estradiol into medium-chain oils often derived from coconut oil. This allows for the production of cohesive, stable formulations, and provides content uniformity and accuracy of dosing.
TherapeuticsMD is leveraging this leading-edge technology to create new bio-identical drug forms and combinations that meet FDA uniformity and stability requirements.
SYMBODA underlies multiple hormone therapy products approved or at various stages of clinical development. Visit the Research section of our website to learn more.
Visit our Partnering page for details on how to leverage this technology by working with TherapeuticsMD.
To learn more about SYMBODA technology in our research pipeline, visit our Research page.